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Abstract 
Paramagnetic metal ions with anisotropic magnetic susceptibilities can shift the proton NMR signals of 
chelating ligands beyond the diamagnetic range of endogenous proton resonances. Such large shifts, along 
with enhanced longitudinal relaxation rates, allow paramagnetic complexes to be exploited as molecular 
imaging probes for MRI. Paramagnetically-shifted imaging probes are detected directly against zero 
background, as opposed to the indirect induced relaxation enhancement of surrounding water molecules, and 
are reviewed herein. The development of ‘smart’ probes that are sensitive to their surrounding environment is 
also being developed, and some of the challenges faced for in vivo imaging are discussed, including issues of 
sensitivity and dose, biodistribution and clearance. Several examples of lanthanide complexes have been 
investigated, and more recently certain paramagnetic transition metal complexes are being considered as 
potential imaging agents. 
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1. Introduction 
Magnetic resonance imaging (MRI) is an important diagnostic tool for medicine and biomedical research due 
to its ability to image soft tissue both non-invasively and with high 3D spatial resolution.  The development of 
MRI contrast agents has dramatically improved the information that can be garnered from MRI imaging, and 
gadolinium(III) complexes are used routinely in the clinic, increasing signal per unit time by enhancing the T1 
relaxation rates of proximal water molecules selectively [1]. However, this indirect method of tracing probe 
location is concentration dependent, whilst the biodistribution of contrast agents is usually heterogeneous, 
and relatively high doses, ca 0.1 mmol/kg-1 are required. Direct detection of a proton-containing tracer 
molecule is possible by MRI, even within the intense endogenous signals from water and fats in the body, by 
exploiting the paramagnetic shift phenomenon encountered in metal complexes with an anisotropic magnetic 
susceptibility. The reporter signal can be shifted away from the diamagnetic window, allowing its visualisation 
against a zero background (Figure 1).  
Figure 1.  Imaging paramagnetically-shifted proton signals against zero background signal in the body. 
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Such an approach is analogous to heteronuclear MRI (31P, 19F, 13C, 15N, 7Li and 23Na), without the concomitant 
sensitivity issues and requirement for specialist imaging coils associated with non-proton MRI [2].  
2. Paramagnetic Induced Chemical Shifts 
The effect of paramagnetic species on NMR signals has been noted since the very beginnings of NMR [3–6]. In 
the 1950s, Bloembergen and Dickinson observed unexpected shifts in the NMR resonances of paramagnetic 
solutions, and subsequently suggested that some paramagnetic ions possess magnetic anisotropy, i.e. the 
magnitude of the electron-induced magnetic susceptibility varies with orientation [7]. A nucleus ‘sees’ the 
time-averaged magnetic moment of unpaired electrons, which is non-zero when the populations of the 
electronic states are not equal to one another. Such a situation occurs when there is a Boltzmann distribution 
across different low-lying energy states, e.g. across the crystal-field splitting in the J manifold in f-block 
compounds, or due to zero-field splitting and spin-orbit coupling in d-block systems. 
 
Figure 2. The nucleus ‘N’ feels the dipolar magnetic field of an unpaired electron ’e-‘, which experiences extra 
field that subtracts (A, C) or adds (B, D) to the external field. Rotational motion averages these to zero for 
isotropic fields (A, B) but to non-zero for anisotropic fields (C, D). 
Unpaired electrons of paramagnetic compounds can therefore produce a large, temperature-dependent 
contribution to the observed shift (obs) of a nucleus, which adds to the orbital diamagnetic (dia) term, and is 
often referred to as the hyperfine shift (HF). Although there are many possible contributions to HF, only the 
pseudocontact term (PCS) and/or the Fermi contact term (FCS) are usually considered, as other contributions 
are negligible.  
𝛿𝑜𝑏𝑠 =  𝛿𝑑𝑖𝑎 +  𝛿𝐹𝐶𝑆 + 𝛿𝑃𝐶𝑆                                               (1) 
The pseudocontact term describes the dipolar interaction (through-space), and the Fermi contact contribution 
describes the direct shielding constant experienced, due to a fraction of the unpaired electron spin density 
present actually at the nucleus of interest, either by direct delocalisation through bonds, or via spin 
polarisation. This term is important for atoms directly bonded to the paramagnetic centre, but is rapidly 
attenuated with the number of separating  bonds [8].  
The ability of lanthanide(III) complexes to induce large paramagnetic shifts was used by Hinckley in 1969 [9], 
and the physical origins were rationalised by Bleaney several years later [10], describing the effects of 
magnetic anisotropy on the observed NMR shifts in lanthanide complexes. Due to the large anisotropy of the 
magnetic susceptibility, short electronic relaxation times and predictable coordination chemistry of the 
trivalent lanthanides, they offer a great deal of potential as paramagnetic ions for NMR applications. The early 
1970s saw an increased interest in the systematic application of paramagnetic shift reagents as tools for the 
organic chemist to elucidate NMR spectra of molecules with a large number of overlapping resonances 
[11,12]; indeed, enantiomerically pure lanthanide complexes have since been used as chiral shift reagents 
[13,14]. Paramagnetic shift agents have also been employed for solid state protein structural elucidation 
[15,16], and have been investigated as potential in vivo shift agents for 23Na+ [17]. 
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Paramagnetically shifted proton signals, such as nuclei in the local chelating ligand structure of a paramagnetic 
metal centre, can resonate at frequencies significantly shifted away from the usual diamagnetic range,  
enabling PARAmagnetically SHIFTed MRI probes, coined ‘PARASHIFT’ probes, to be imaged in vivo [18]. 
Paramagnetic-induced hyperfine shifts have also been exploited in the field of Chemical Exchange Saturation 
Transfer (CEST) imaging over the last 20 years [19–21], although the long scan times, continual irradiation with 
saturating frequencies, and problems associated with field inhomogeneity, limit the potential use of 
‘PARACEST’ in humans. Notably, the rise in applications of paramagnetic complexes has also pushed advances 
in the development of more elaborate theoretical approaches for the calculations of hyperfine shifts, that go 
beyond the assumptions of Bleaney’s theory [22–28].  
3. PARASHIFT Probes for Imaging 
PARASHIFT molecular probes need to be water soluble, stable in solution, and non-toxic at the imaging 
concentrations used, in order to be applicable in vivo. It is imperative that PARASHIFT probes are kinetically 
and thermodynamically stable with respect to metal ion dissociation, as much like free Gd3+, other free Ln3+ 
ions are highly toxic and can trans-metallate in the body [29]. Compared with other imaging techniques 
(nuclear imaging, luminescence imaging) MRI is insensitive. Thus, it is important to maximise the signal-to-
noise ratio (SNR) in the probe design. Ideally, the reporting proton resonance must be shifted as far away as 
possible from the endogenous protons so that a large excitation bandwidth can be used to allow the use of 
fast imaging sequences [18]. The reporter group must also provide a large single NMR signal, and therefore it is 
important to consider the symmetry, assess the possibility of forming diastereoisomers, and study the 
exchange dynamics of potential imaging resonances [30]. In addition to the hyperfine shift, paramagnetic 
centres can also enhance the relaxation rates of surrounding nuclei, which can be exploited to enhance 
sensitivity. The paramagnetic induced nuclear relaxation can give rise to rapid longitudinal relaxation rates, R1 
(i.e. 1/T1), facilitating fast-pulsed NMR techniques [31]. The linewidth of the reporting resonance, however, 
needs to be narrow to avoid SNR losses due to T2 and the ratio R1/R2 should be as close to unity as possible 
[18,31,32]. 
One of the first examples of chemical shift selective imaging with a paramagnetic complex was published in 
1996 by Aime, Botta and co-workers, using the complex [YbL1]-, known as YbDOTMA [33]. The intense C4-
symmetric methyl 1H signal, at -14 ppm (27°C, 4.7 T, R1 = 15 s-1, R2 ~ 30 s-1, was imaged selectively in phantoms 
at 4.7 T (200 MHz), using a 2D spin echo with 5 ms sinc pulse. This first proof-of-concept study successfully 
demonstrated that paramagnetic complexes could be imaged selectively in the presence of water at 
physiologically relevant concentrations (LD50 = 10.5 mmol/kg) (Figure 3). However, the 2D single slice imaging 
experiment took over 6 h to observe signal from the 3 mM solution.  
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Figure 3  (Left) Structure of [LnL1], (LnDOTMA)- (Right) Adapted from reference [33]. 2D spin echo chemical shift 
selective image of a phantom containing a series of aqueous solutions of [YbL1]- from 0-100 mM. A 5 ms sinc 
pulse was used for the 90o pulse and the transmitter offset was placed on the methyl group of interest to give 
the chemical shift selection. A 5 ms sinc pulse in the presence of a gradient was used for the 180 o pulse, giving 
slice selection. Slice thickness 4.5 mm, echo time 23 ms, relaxation delay = 0.15 s, number of phase encoding 
steps = 64, number of complex pairs = 128, number of transients = 2048. In plane spatial resolution = 0.625 mm 
× 0.625 mm (voxel size ca 1.8 mm3). Copyright © (1996) Wiley-Liss, Inc., A Wiley Company. 
The NMR properties of other [Ln.L1]- complexes were investigated by Bansal and co-workers, and [TmL1]- was 
deemed the most suited to chemical shift selective imaging, with its sharp methyl resonance at -100 ppm 
(35°C) [34]. In 2014 Faber et al. successfully employed [TmL1]- in cell-labelling studies in vivo; the complex was 
internalised into HT-1080 (human fibrosarcoma) cells prior to injection, and tracked by MRI in mice for 8 days, 
at an equivalent dose of ca. 1.6 mmol kg-1 [35] . 
 
Figure 4   Structures of carboxylate Ln PARASHIFT probes optimised for imaging 
In 2013, Parker and co-workers began to investigate the optimisation of a series of PARASHIFT lanthanide 
complexes, analysing both shift and relaxation properties, to inform judicious design of imaging probes [18]. 
Imaging sensitivity relies on the reporter group structure, its shift and relaxation properties [36]; PARASHIFT 
probes were designed with a tert-butyl reporter group placed about 6.5 to 7 Å from the lanthanide(III) ion 
enclosed within a cyclen-based macrocycle ([LnL2] and [LnL3]+, Figure 4) to optimise fast longitudinal 
relaxation, whilst negating SNR losses to T2 [18,23]. The tert-butyl group provides nine, in [LnL2], or eighteen, in 
[LnL3]+ magnetically equivalent 1H nuclei, giving a relatively intense resonance between -20.5 and +10.8 ppm 
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(22°C) depending on the lanthanide and complex [18]. Preliminary in vivo PARASHIFT imaging was performed 
on renally intact mice administered with clinically relevant doses (0.03 mmol/kg) of [DyL3]+ by intravenous 
injection, at 7 T. Short echo times (4 ms) and a narrow excitation bandwidth of 5 kHz were used, to reveal 
[DyL3]+ within skeletal muscles [18]. In pursuit of better sensitivity, Parker and co-workers developed new 
PARASHIFT agents with reporter groups shifted much further and  > 70 ppm from the water/fat signals so that 
shorter excitation pulses (i.e. wider excitation bandwidths) could be used. It was hypothesised that increasing 
the excitation bandwidth to 20 kHz would significantly speed up image acquisition [31]. The structural 
modification from carboxylate ([LnL2]) to methylphosphinate ([LnL4], Figures 5 and 6) chelating pendants was 
found to have a dramatic effect on the tert-butyl resonance frequency (Figure 5) [23].  
 
 
Figure 5. Schematic representation of the experimentally measured chemical shifts of tert-butyl signals in [LnL2] 
(top) and [LnL4] (bottom)  (D2O, 22°C) (yellow – Tm, green – Er, magenta – Yb, black – Ho, red- Dy, blue –Tb.)  
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The chemical shift range of the tert-butyl resonances in [LnL4], 140 ppm (67 ppm [Tm] to -77 ppm [Tb]), is 
significantly larger than the range of [LnL2], 32 ppm (11 to -21 ppm), and further detailed studies of the 
hyperfine shift and relaxation properties of a range of tricarboxylate and triphosphinate 12-N-4 macrocyclic 
lanthanide complexes have shown that even small ligand variations can induce very large changes in the 
magnetic anisotropy [23,37]. The loss of the axially coordinating water molecule in the [LnL4] systems (with 
respect to [LnL3]) is associated with this drastic increase in both shift and relaxation [36,37]. The reason for the 
much larger shift of the tert-butyl group in the triphosphinate  complexes [LnL4] is the change in the 
orientation and size of the major axial component of the magnetic susceptibility tensor, which points  directly 
towards the reporting tert-butyl resonance.[30] The tert-butyl proton signal of [DyL4] (Figures 5 and 6) 
resonates at -75 ppm (22°C), > 20 kHz away from the water signal at 7 T and is therefore suitable for fast 
imaging sequences.  
 
 
Figure 6.  1H NMR spectrum and structure of [DyL4] (D2O, 9.4 T, 22°C), investigated in reference [23] 
 
The anionic bismethylphosphinate complex shown below ([DyL5]-, Figure 7), linked a carboxylate group close to 
the pyridine ring in order to improve its biodistribution with respect to the cationic analogue, i.e. a 
bismethylphosphinate complex similar to [LnL3]+. [38] [DyL5]- was imaged in vivo with an optimised 3D gradient 
echo sequence at 7 T. The 18 proton tert-butyl NMR signal was excited at -60 ppm using a 20 kHz excitation 
bandwidth and much shorter echo times (TE = 1.45 ms, TR = 2.87 ms) and the image time was reduced to ca 60 
s per 3D image (of 16 slices). An impressive detection limit of about 20 μmol/dm3 was achieved at this 
temporal resolution, which allowed dynamic time series of images to be implemented to follow the kinetics of 
the molecular probe within the body, following the tail-vein injection of a single 0.04 mmol/kg dose of [DyL5]- 
(Figure 7). 
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Figure 7.   From reference [38] with permission. (Top left) Time series analysis of PARASHIFT concentration from 
selected regions of interest in six mice. In vivo 3D gradient echo imaging of renally intact mice administered 
with 0.04 mmol/kg [DyL5]- by intravenous tail vein injection. Imaged using 7 T preclinical MRI system with a 
39 mm birdcage RF coil, TE= 1.45 ms, TR= 2.87 ms, 20 kHz excitation bandwidth, voxel sixe = 32 mm3, 62s per 
3D image set (of 16 slices). (Top right) Structure of [DyL5]-. (Bottom) PARASHIFT signal from [DyL5]- (colour scale) 
overlaid onto conventional structural MRI scans. Each column represents a different time point post injection. 
Within each column the data represent different spatial axial slices through  the mouse. Copyright © (2016) The 
Authors Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society 
for Magnetic Resonance in Medicine.  
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Over the last 20 years several examples of PARASHIFT imaging have been reported using cyclen-based 
macrocyclic lanthanide complexes that are relatively simple to synthesise, mainly by the groups of Hyder [39–
43] and Bansal [34,44,45], as well as optimised imaging probes synthesised by Parker and co-workers [38]. The 
magnitude of the paramagnetic shift is sensitive to physiological conditions including temperature, and efforts 
to convey functionality to these imaging probes has been exploited in spectroscopic imaging techniques, 
leading to sensing applications in vivo.  These are described in more detail in the following section.  
4. In vivo Sensing with PARASHIFT Probes 
Selective excitation of PARASHIFT agents using 3D gradient echo MRI allows the spatial distribution of the 
probe to be determined, with the intensity of the signal in each pixel determining the image contrast. It is also 
possible to extract more information using magnetic resonance, than simply probe location, if the frequency of 
the PARASHIFT agent’s reporting nuclei can change in response to their surrounding environment; MRS 
imaging (MRSI) is the spatial mapping of spectroscopic information, rather than simply probe concentration, 
and is often referred to as chemical shift imaging (CSI), spectroscopic imaging (SI), or multi-voxel spectroscopy. 
MRSI can be performed with responsive contrast agents, in order to map physiological parameters such as 
temperature, pH, and ion concentrations.  
 
4.1. Temperature Sensing 
The paramagnetic hyperfine shifts of PARASHIFT nuclei are inherently temperature dependent because 
magnetic anisotropy derives from the Boltzmann population of energy states. Therefore, the chemical shifts of 
protons within PARASHIFT complexes change with temperature. It is important to note that paramagnetic 
shifts are not necessarily expected to show a linear dependence with temperature, a T-2 dependency of the 
pseudo-contact shift is predicted for lanthanide ions based on Bleaney theory, for instance [10]. However, over 
small (physiological) temperature ranges an approximate linear dependence is observed and thus linear 
temperature coefficients are often quoted [46].  
 The most widely applied MRS thermometry method in the literature is the ‘proton resonance frequency’  
technique, which exploits the temperature-dependent hydrogen-bonding of the water protons; the proton 
resonance exhibits a linear shift response to temperature, with a very small temperature coefficient of 
0.01 ppm/°C [47,48]. This low thermal sensitivity limits the error of temperature measurements to ca 2°C [49], 
requires fat-suppression techniques, and is impractical for measuring small temperature differences in vivo.  In 
1996, [YbL1]- (Figure 3) was proposed as a temperature-sensitive MRS probe and in vitro spectroscopic 
investigations of the methyl resonance revealed a linear -0.04 ppm/°C temperature coefficient, four-times 
greater than that of water [33].  Meanwhile, Hentschel and co-workers began to investigate the thermometry 
properties of [PrL6] (Figure 8) [50,51]; the methoxy group at -24.1 ppm (22°C, relative to the water signal) was 
selectively imaged in 10 mM phantoms, and a linear shift dependence with temperature of 0.13 ppm/°C was 
observed. 
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Figure 8.  Structures of selected temperature responsive MRS probes  
The methoxy shift was shown to be independent of pH and was used to measure the absolute temperature of 
the liver in a rat model, and verified by a rectal thermocouple (deviation < ± 1°C), although a high dose was 
required for this study (1 mmol/kg). Hentschel and co-workers later confirmed that the complex could be used 
to map temperature through the 2D spin echo spectroscopic imaging of phantoms [52–54].  
A comparison of the NMR properties of [YbL1]- with the analogous Pr, Tb, Dy and Tm complexes showed that 
[TmL1]- had the greatest temperature coefficient, 0.57 ppm/°C, and its chemical shift was found to be 
insensitive to complex concentration, pH and the presence of Ca2+ ions [34]. [TmL1]- was successfully employed 
for temperature mapping in rats with millimetre resolution, using a frequency selective pulse [40,44,45]. 
However, these studies relied on renal ligation and high doses of 1-2 mmol/kg in order to supress the fast 
clearance of [TmL1]- via the kidneys. Despite the incredibly short half-life of [TmL1]- in the blood (ca 7 min), Sled 
and co-workers managed to measure the internal temperatures of the aorta, inferior vena cava and kidney 
within this time window at 11.7 T, following a single bolus injections of 0.7 mmol/kg within physiologically 
intact mice [55]. 
It is becoming clear that the size and T-sensitivity of the resonant frequency of a paramagnetically shifted 
reporter resonance is a property of both the lanthanide ion and the ligand used to complex it. No longer can 
all-embracing theories, such as Bleaney’s,[10] be invoked to rationalise, let alone predict behaviour.[22,23,28]  
For example, it has been noted that Tm complexes often produce much larger shifts with larger T coefficients 
that might have been expected. For many of these it is likely, and has been predicted[56] that the relative 
thermal population and anisotropy of the individual lanthanide ion mJ sub-states needs to be considered.  Each 
mJ sub-level has a different magnetic susceptibility anisotropy: their relative order is determined by the ligand 
field[22] and their energy separation with respect to kT (2.5 kJ/mol at 298K) can strongly influence their 
weighted population and hence the T-dependence of the overall paramagnetic shift.[56] 
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Zuo et al. investigated the thulium(III) complex of the tetraphosphinate ligand, known as DOTP ([TmL7]5-, 
Figure 8) as a potential probe for MR thermometry [57] (notably, Ln3+ complexes of DOTP were originally 
studied as MR probes to distinguish intra- and extra- cellular concentrations of Na+ in vivo, by 23Na and 31P MR 
imaging [17,58]).  
The H6 proton signal of [TmL7]5- (Figure 8) resonates at -142 ppm (37°C) with a relatively narrow line width (ca 
300 Hz at 7 T) and a significant linear temperature dependence of 0.89 ppm/oC, allowing greater thermal 
resolution than with [TmL1]-. Similarly to [TmL1]- thermometry, the chemical shift of the [TmL7]5- proton 
resonance is unaffected by pH (between 6.5 and 8.5), and in vivo thermometry has been demonstrated in 
renally ligated rats dosed with 1 mmol/kg of [TmL7]5- [57]. However, the sensitivity of the complex to variations 
in Ca2+ concentration reduces the accuracy of temperature measurement in vivo. 
The C4 symmetric complex, [LnL8]-, (i.e. analogous lanthanide complexes of the commercial gadolinium 
contrast agent Dotarem [1], Figure 8) has also been employed successfully as an MSRI thermometry probe 
[59,60]; the [TmL8]- H5 resonance at -227 ppm (37°C) has a temperature coefficient of 0.91 ppm/°C, and is 
insensitive to variation of both pH and [Ca2+]. In vivo temperature measurements were performed, at 9.4 T, on 
tumour-bearing mice infused with 1-2 mmol kg-1 [TmL8]- and with scan times of ca 4 min [60]. Such a dose is 
generally regarded as being beyond the safe dose for analogous Gd MRI contract agents, and the ability to 
obtain fast temperature changes is limited by the acquisition time.  
Tetra-amide based lanthanide(III) complexes have been thoroughly investigated for use in PARACEST imaging. 
The efficiency of CEST, i.e. detecting the signal loss of a pool of protons that are exchanging with a selectively 
saturated proton signal, depends upon the rate of exchange with respect to the chemical shift difference of 
the two proton pools, and is thus enhanced by large frequency differences. PARACEST agents tend to exploit 
exchangeable protons (i.e. NH, OH) within paramagnetic complexes, that are significantly shifted away from 
the bulk water signal with which they exchange. In 2011 Hyder [61,62], Sherry and co-workers investigated the 
possibility of dual modality MRI by combining PARACEST and PARASHIFT imaging techniques to detect the 
Eu(III) complex of the carboxylate-appended tetra-amide ligand ([EuL9]-, Figure 8) in phantom solutions [63]. In 
vitro experiments of 20 mM phantoms were performed, using MRSI to detect the non-exchangeable cyclen 
proton H4, which has the largest temperature coefficient of 0.13 ppm/°C. Direct MRSI of [EuL9]- revealed the 
concentration and temperature information per pixel, as a means to adjust subsequent CEST images for 
quantitative information, which image the molecule indirectly due to exchange with water. This in vitro 
experiment was performed at 11.7 T and required relatively high saturation powers for the CEST imaging, with 
both long MRSI (4.5 min) and CEST (7 min) imaging times.  
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Figure 9. From reference [38] with permission.  In vivo spectroscopic imaging of renally intact mice 
administered with 0.04 mmol/kg [DyL5]- by intravenous tail vein injection. (Top) Spectral grids for three of the 
MRSI slices acquired 1 minute after intravenous injection (Bottom left) Reconstructed PARASHIFT tissue 
distribution (derived from peak area for each voxel in 3DSI experiment) at 1 minute and 25 minutes post 
injection.  (Bottom right) Spectra extracted from selected regions of interest. Imaged using 7 T preclinical MRI 
system with a 39 mm birdcage RF coil, TE= 0.73 ms, TR= 7.69 ms, 20 kHz spectral width, 63s per data set. 
Copyright © (2016) The Authors Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf 
of International Society for Magnetic Resonance in Medicine.  
 
Parker and co-workers have successfully used MRSI of PARASHIFT agents to map temperature information 
[18,38,46]. MRSI was performed in vivo on renally intact mice, following intravenous injection of 0.04 mmol/kg 
of [DyL5]- shown in Figure 9 (the temperature coefficient of the tert-butyl resonance was 0.28 ppm/°C in 
mouse plasma). A shift in the tert-butyl frequency between the bladder and the kidney were observed, 
indicating a 4°C difference in temperature between these organs, and imaging was performed at relatively 
high temporal resolution (63 s per image set) [38].  
The intrinsic temperature sensitivity of paramagnetically shifted resonances has enabled the development of a 
new tool for in vivo temperature measurement. Accurate thermometry requires the temperature coefficient 
to be significant enough for high temperature resolution, without being too large to cause spatial distortions in 
the frequency encoding dimension. It is important that the reporter signal has a narrow linewidth, to ensure 
that chemical shift data can be readily extracted, and that it responds to temperature only, without shifting 
due to modulation of other external variables.  
4.2. pH Sensing 
Whilst the hyperfine shift of PARASHIFT agents has a dependence upon temperature, the chemical shift may 
also be sensitive to other external variables, such as pH, which can be exploited for MRI sensing.  [YbL7]5- 
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(Figure 8)  can protonate at all four of the phosphonate groups (equations 2-5), giving rise to a pH dependence 
of the proton resonance frequency [64]:  
 
[Yb(HL)]4- ⇌ [YbL]5-  + H+    pKa4 = 7.76 (2) 
[Yb(H2L)]3- ⇌ [Yb(HL)]4- + H+    pKa3 = 6.56 (3) 
[Yb(H3L)]2- ⇌ [Yb(H2L)]3- + H+    pKa2 = 5.33 (4) 
[Yb(H4L)]- ⇌ [Yb(H3L)]2- + H+    pKa1 = 3.86 (5) 
 
The chemical shift separation between selected pairs of 1H resonances was found to have a linear dependence 
that was negligibly affected by complex concentration, ionic strength and, most crucially, temperature; 
allowing for ratiometric measurement of pH. NMR measurements of pH were also achieved by Zuo and Sherry 
using [TmL7]5-, where it was found that H6 (Figure 8) has a linear pH dependence between of -3.27 ppm/pH unit 
in the pH range 5.5 to 7.5, but was also temperature dependent [65]. A deconvolution of variables was 
therefore necessary to unravel the two different variables, using two different proton signals with different 
response coefficients to each variable using simultaneous equations (equations 6 and 7):  
∆𝛿(𝑖) = 𝐶𝑇(𝑖)∆𝑇 + 𝐶𝑝𝐻(𝑖)∆𝑝𝐻 (6) 
∆𝛿(𝑗) = 𝐶𝑇(𝑗)∆𝑇 + 𝐶𝑝𝐻(𝑗)∆𝑝𝐻 (7) 
Where CT(i), CpH(i), CT(j), CpH(j) are the linear coefficients of the temperature and pH dependence of the 
chemical shifts in [TmL7]5- as measured in vitro for protons i and j respectively. This technique was used to 
simultaneously measure the temperature and pH changes in live rats undergoing ultrasonic hyperthermia 
treatment, following local injection of 0.15 mmol/kg [TmL7]5- [66]. Analysis of the chemical shifts of H2 and H6 
(Figure 8) allowed temperature and pH mapping that was concurrent with inserted pH electrode and 
thermocouple measurements. Hyder et al. used a similar method to measure the brain temperature and pH of 
rats by focusing on two pairs of proton resonances either side of the water resonance [67,68]. Animals were 
renally ligated and injected with ca 1.5 mmol/kg of [TmL7]5- and the resonances of each pairs of shifts were 
acquired separately from each other. Additional animal studies reduced the dose of complex to 1 mmol/kg and 
2D CSI images of the brain (voxel size 10.2 μL) were obtained in 6 minutes [39]. The efficiency of the 2D 
mapping was improved and extended to 3D using spherical encoding instead of rectangular, which reduced 
the [TmL7]5- dose to 0.5 mmol/kg, and increased the resolution (voxel size 1 μL) with 5 min scan times [41]. 
Extracellular pH maps of rat brains were generated in animals bearing 9L and RG2 tumours, and [42] the 
extracellular pH within tumours (7.0) was found to be lower than that in normal brain tissue (7.4), as can be 
seen below in the pH/T sensing experiment, Figure 10. 
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Figure 10.  From reference [42] with permission. Representative extracellular pH maps of rats bearing (A) 9L 
and (B) RG2 tumors. (i)  T2-weighted image showing tumor localization (tumour = blue outline; brain = brown 
outline). (ii) A portion of the 3D chemical shift imaging (CSI) data for the slice in (i). (iii) Examples of spectra 
from intra-tumoural and peri-tumoural voxels. (iv) quantitative maps of the extracellular pH were obtained 
using multiple [TmL7]- peaks and their respective pH sensitivities. Imaged using a 11.7 T horizontal-bore 
spectrometer, TR = 5 ms, 35 kHz spectral width. Copyright ©(2016) John Wiley and Sons, Ltd. 
The complex [TmL7]5- was also used to map the effectiveness of temozolomide treatment (a chemotherapy 
drug) on U251 tumours by monitoring the pH of the tumour and brain [69], and demonstrated that the pH of 
both tumour and brain tissue was higher in treated rats. Although these studies demonstrate the successful 
use of [TmL7]5- to map temperature and pH in vivo, high doses were required with renal ligation. 
  
Figure 11. Structure of [LnL10]5- 
The phosphonate-appended tetra-amide complex [GdL10]5- (Figure 11) has been studied as a pH responsive T1 
contrast agent because the relaxivity of the complex is pH dependent [70–72]. The Yb3+ and Tm3+ complexes 
have been investigated as dual PARACEST and PARASHIFT probes [73]. The chemical shifts of the non-
exchangeable resonances are pH dependent with the most sensitive measurement, 5.2 ppm/pH unit (35°C), 
arising from the difference between H6 and H8 in [TmL10]5-. This chemical shift difference also varies with 
temperature, 0.3 ppm/°C (35°C). Determination of pH and T simultaneously required two pairs of chemical 
shifts, H6-H8 and H2-H3, each with different pH/T sensitivities. Phantoms studies were used to compare the use 
of PARASHIFT and PARACEST in pH mapping which demonstrated that although CEST experiments could 
provide better spatial resolution PARASHIFT experiments had much higher pH sensitivities. High resolution pH 
mapping of [LnL10]5- may be feasible using a combination of PARACEST and PARASHIFT techniques. However, 
further in vitro experiments are required to determine any sensitivities to cations, e.g. Ca2+, Mg2+, before in 
vivo capability can be realised.  
Parker and co-workers sought to introduce pH responsive behaviour to their optimised PARASHIFT probes 
through the addition of a phosphonate group adjacent to the tert-butyl reporter group ([LnL11]-, Figure 12) 
[46]. The PARASHIFT tert-butyl resonance of the pH sensitive trimethylphosphinate (Ln(PMe3)) probe was 
+74 ppm for the Tm3+ complex to -78 and -83 ppm for the Dy3+ and Tb3+ complexes respectively (22°C). The 
chemical shift of the reporter varies with pH (Figure 12) and pKa values of [LnL11]- averaged 7.16 (±0.06) in D2O. 
The total shift range of this pH sensitivity and the linear temperature dependencies were both found to vary 
between lanthanides. The dual temperature and pH sensitivity of the probe means that the co-injection of two 
Ln3+ complexes is required to gain chemical information of tissues. Tm3+ and Dy3+ complexes were used for in 
vivo studies due to their large shift and similar longitudinal relaxation rates at 7 T. The two complexes were 
administered intravenously at 0.04 mmol/kg in renally intact mice. A triple imaging experiment allowed 
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simultaneous acquisition of the water signal and each of the well-separated tert-butyl signals and was 
achieved by dual, back-to-back RF pulses to excite the Dy and Tm complexes consecutively; a spectral width of 
60 kHz was used to encompass all three signals. No specific excitation pulse was applied to the water 
resonance frequency as sufficient excitation was achieved with the two original pulses. Simultaneous 
equations can be solved for the chemical shift of the two tert-butyl resonances in order to extract the T and 
pH. These studies assessed the pH and temperature of the liver to be 7.1 and 34.5°C and the bladder to be 6.8 
and 31°C.  
 
Figure 12. Stacked 1H NMR spectra of [DyL11]- at varying pD (D2O, 11.7 T, 22°C) 
Altered extracellular pH in vivo is associated with certain chronic diseases. There are very few non-invasive 
methods to quantify pH in vivo. 31P MRS utilises the chemical shift of pH sensitive, phosphorus-containing 
metabolites, although the analogous use of pH sensitive 1H metabolites is less well established. PARASHIFT 
molecular probes offer an alternative non-invasive MR technique, however the nature of the pH responsive 
group must be chosen carefully. The pKa value must be within a biologically relevant range and should be 
insensitive to additional external variables, such as small changes in protein or local calcium or magnesium ion 
concentrations.   
5.  Important Practical Considerations for in vivo Imaging 
Many examples of responsive PARASHIFT molecular probes have been employed successfully in imaging 
experiments, mainly with C4-symmetric DOTA-type lanthanide complexes [TmL1]- and [TmL7]5-, and tert-butyl 
appended Dy(III) and Tm(III) macrocyclic complexes. In order for PARASHIFT imaging to have clinical relevance 
however, it is important to consider the dose and method of administration required to produce adequate 
image sensitivity, as well as the pharmacokinetics/biodistribution of the molecular probe, and their 
interactions with other physiological species e.g. proteins and endogenous cations.  
Most PARASHIFT agents studied to date suffer from fast clearance in the body, limiting the time-frame in 
which to image the molecular probe in organs other than the bladder to tens of minutes. Many early imaging 
studies were limited by the use of large doses (>0.1 mmol/kg, the clinical dose advised for DOTAREM), renally 
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ligated animals to eliminate clearance pathways, or continuous infusion of the PARASHIFT probe to maintain 
sufficient signal intensity.  
Hyder et al. encapsulated [TmL7]5- complex (Figure 8) in 1,2-dipalmitoyl-sn-glycerophosphocholine (DPPC) 
liposomes in order to enhance local concentrations, and the encapsulation process apparently had little effect 
on the chemical shifts of the [TmL7]5- protons[74]. In vitro MRSI experiments suggested signal amplification 
could be achieved using nanomolar amounts of liposomes compared to free [Tm.L7]5-. Significant in vivo 
improvements in sensitivity have been achieved in more recent studies, more than 20-fold [38,46], with 
carefully designed complexes. Recently, investigation of the co-infusion of [TmL7]5- with an anionic transport 
inhibitor showed enhanced probe concentrations, albeit with high infusion doses of 1 mmol/kg [43].  
Strategies to enhance the sensitivity of these responsive probes have been considered. Greater signal intensity 
(SI) per unit time can be gained by working at higher field of course, but increasing the SI by maximising the 
local probe concentration has also been considered. These approaches include the use of multimeric 
complexes, where the probes are conjugated to a passive biocompatible entity,[75] or the use of non-
covalently assembled adducts where the probes are locally concentrated inside a liposome or micelle.[74] 
Such higher molecular volume systems clear more slowly form the body, lengthening the detection window. In 
the future, conjugation to efficient and cheap targeting vectors can be envisioned, for example based on 
medium MW peptide carriers. Other approaches that can be employed to alter the pharmacokinetics involve 
changing the chemistry of the molecular probe; Parker found that anionic PARASHIFT complexes cleared 
slightly more slowly than cationic complexes,[18,38] and both Parker and Hyder sought to reduce clearance 
rates by increasing the size of the molecular probe by conjugation to biopolymers [75] or developing 
dendrimers containing [TmL1]- [76]. Unfortunately, Hyder et al found that the loss of the C4 structural 
symmetry resulted in the loss of sharp resonances and severe signal broadening was observed as the 
dendrimers increased in size.   
The phosphonate groups in compounds such as [LnL7]5- and [LnL10]5- are known to bind divalent metal ions, 
often forming stable adducts, and interferences from interactions with Ca2+ ions within the body may pose a 
problem for in vivo imaging [77]. Although some studies have considered the effect of Ca2+ concentration [39], 
absolute determination of pH and/or T in vivo is impractical using these probes. Furthermore, injection of 
[LnL7]5- leads to a drop in blood pressure as it binds to available cations in the blood [78].  
Hudson and Milne modified the tetra-amide structure of [EuL9]5- with propargyl arms to prevent problems with 
Ca2+ binding and the chemical shifts were found to be independent of both pH and [Ca2+]. However, this 
renders the complex tricationic, which may give rise undesirable biodistribution and toxicity issues. The 
temperature sensitivity (1.76 ppm/°C) was reproducible when performed in pseudo-biological conditions, but 
no in vivo studies were reported [79]. Similarly, in control experiments in vitro, the pH and T sensitivity of 
complexes of [LnL11] has been shown to be independent to variation of both Mg and Ca ion concentrations, 
over the range 0.5 to 5 mM.[46]    
 
5.1. Towards Non-Lanthanide PARASHIFT agents 
The medical community routinely use Gd-based contrast agents for MRI, but in 2006 links to the rare but 
severe illness nephrogenic systemic fibrosis were found [80], and in 2017 the European Medicines Agency has 
documented gadolinium accumulation in patients’ brain tissue, leading to restrictions in the use of the most 
commonly used contrast agent, [Gd.DTPA]2- [81]. PARASHIFT agents have the potential for better sensitivity 
than conventional relaxivity Gd3+ contrast agents because they are imaged directly, against zero background, 
and therefore lower concentrations of lanthanide complexes can be used for imaging studies. There has also 
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been an impetus to look towards d-block metals to replace gadolinium contrast agents [82–84], and more 
recently the search for new PARASHIFT agents based on paramagnetic d-block systems.  
Morrow and co-workers have synthesised stable Fe(II) and Co(II) complexes using 9-N-3 and 12-N-4 based 
ligands appended with 6-methyl-2-picolyl groups (Figure 13). These six-coordinate aza-macrocyclic based 
ligands were found to stabilise the high-spin forms of Fe(II) and Co(II) due to the weaker ligand field produced 
as a result of the steric demand of the 6-methyl substituted pyridines. The complexes are paramagnetic with 
an anisotropic magnetic susceptibility that gives a relatively large hyperfine shift [85–87]; for example the 
proton signals within 12-N-4-based Fe(II) and Co(II) complexes span the range +300 to −80 ppm, compared to 
LnDOTA signals that span +300 to −500 ppm [Dy] and +400 to −300 ppm [Tm].[88] The transition metal 
complexes [ML12]2+ and [ML13]2+ were found to be kinetically inert in biological media and the chemical shifts 
are insensitive to pH (within physiological range) and biological ions (PO34-, CO32-, Zn2+, Ca2+). Linear 
temperature dependence was observed for all complexes and the largest temperature coefficient was 0.52 
ppm/°C for [Co(TMPC)]2+.  
 
 
Figure 13.     Structures of 9-N3 and 12-N4 transition metal based PARASHIFT probes 
More recently, the methyl groups in the di- picolyl complexes [ML14]2+ and [ML15]2+ have been investigated 
(Figures 13 and 14) [87]. [ML14]2+ exhibited similar MR properties to the tetra- picolyl, [ML13]2+. The picolyl-
methyl shifts of all complexes were shifted well outside the diamagnetic region, between -22 and -113 ppm 
(25°C). The additional methyl groups in [ML15]2+ were found to shift in the opposite direction to the picolyl-
methyls (Figure 14). The presence of two highly shifted resonances could allow for more accurate temperature 
measurements and the temperature coefficients ranged from 0.1 to 0.58 ppm/°C. However, for both Co2+ 
complexes the linewidths of the methyl resonances were extremely broad, reducing the potential for use in 
vivo. The linewidths of the analogous Fe complexes were significantly narrower, but were less further shifted.  
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Figure 14. Adapted from reference [87] with permission. 1H NMR of [FeL15]2+ at 100 mM NaCl in D2O, pD 7.2, at 
25 oC for 10 mM complex. The proton resonances of pyridine and N-methyl groups on 12-N4 are labelled CH3-
Pyr and CH3-N, respectively. Solvent peak is labelled “S”. Inset shows the effect of increasing temperature on 
the 1H resonance of N-CH3. Copyright © (2018) The Royal Society of Chemistry.  
 
New and co-workers have also developed a Co(II) based PARASHIFT complex that exhibits distinctive NMR 
responses to anions in aqueous solution [89]. The paramagnetically shifted N-Me resonance of CoMe6TrenCl 
was observed to give a distinctive spectral profile within the 180-130 ppm region upon reversible binding of 
fluoride, citrate, lactate and acetate.  
Despite these in vitro spectroscopic studies with d-block PARASHIFT complexes, currently no imaging studies 
have been reported to date and cobalt toxicity may be an issue for Co-based probes; optimised probes for 
imaging have not yet been designed, and little has been done in terms of modelling the shift and relaxation 
properties of paramagnetic d-block systems, where the contact shift is more significant due to an increase in 
spin delocalisation onto the ligand in coordination systems [90–93]. 
6. Conclusions 
Paramagnetic probes offer the chance to significantly increase the information that can be extracted non-
invasively by MRI. Monitoring PARASHIFT resonances with MRSI techniques has significantly reduced scan 
times compared to diamagnetic MRSI and PARACEST imaging, and can be performed on a clinical scanner with 
no hardware modifications. Real-time monitoring and mapping of physiological processes can assist in the 
understanding and diagnosis of various diseases, and although only temperature and pH have been thoroughly 
investigated to date, careful selection of functional groups may enable the future monitoring of other useful 
biological markers such as cation concentration or enzyme activity.  
Additional work on the conjugation of targeting vectors onto PARASHIFT probes may also increase the 
clearance times and enable specific tissues/organs/pathologies to be monitored in real time. It is likely that the 
first such studies will address imaging diseased kidneys and liver organs, as these are the simplest to address in 
this challenging work.   
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